SART3 peptide cancer vaccine (Kurume University)

N/A

Report date: 2024/12/11 10:05:07

Base Information

Drug NameSART3 peptide cancer vaccine (Kurume University)

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKurume University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKurume University

Active IndicationsN/A

Inactive IndicationsColorectal Neoplasms

ATC CodeN/A